Cornerstone Partners Capital Management, LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 30, 2026), Cornerstone Partners Capital Management, LLC reported 6 stock positions worth $34.4 million. Its top holding was State Street SPDR S&P Global (GNR) at 63.7% of the portfolio, followed by iShares Core S&P 500 ETF (IVV, 14.3%) and iShares Core US REIT ETF (USRT, 11.5%). Compared with Q1 2026, it sold out of 1 and reduced 5. The biggest sale was iShares Core US REIT ETF (USRT, shares −39%).
- Most Recent 13F
- Q2 2026
- Location
- CHARLOTTESVILLE, VA
- CIK
- 0001845620
- Portfolio Value
- $34.4M (Q2 2026)
- SEC Filing
- 0001725547-26-000266 ↗ filed Jul 30, 2026
Holdings Value
Holdings 6 stocks · $34.4M
| GNR State Street SPDR S&P Global | 63.69% | 325,320 | $21.9M | Reduce -7.7% |
| IVV iShares Core S&P 500 ETF | 14.31% | 6,571 | $4.9M | Reduce -4.2% |
| USRT iShares Core US REIT ETF | 11.50% | 59,495 | $4.0M | Reduce -38.7% |
| IEFA iShares Core MSCI Eafe ETF | 5.91% | 21,042 | $2.0M | Reduce -4.2% |
| IEMG iShares Core MSCI Emerging | 3.35% | 13,905 | $1.2M | Reduce -4.8% |
| AMPX Amprius Technologies Inc. | 1.24% | 30,706 | $426K | No change |
Portfolio Sells Q1 2026 → Q2 2026
| USRT iShares Core US REIT ETF | Reduce -38.7% | 11.50% | −2.77 |
| GNR State Street SPDR S&P Global | Reduce -7.7% | 63.69% | −1.64 |
| RYTM Rhythm Pharmaceuticals Inc. | Sold out | 0.00% | −0.53 |
| IEMG iShares Core MSCI Emerging | Reduce -4.8% | 3.35% | +0.82 |
| IEFA iShares Core MSCI Eafe ETF | Reduce -4.2% | 5.91% | +0.97 |
| IVV iShares Core S&P 500 ETF | Reduce -4.2% | 14.31% | +3.19 |
Portfolio Buys Q1 2026 → Q2 2026
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 6 | $34.4M | GNR, IVV, USRT, IEFA, IEMG |
| Q1 2026 | 7 | $40.3M | GNR, USRT, IVV, IEFA, IEMG |
| Q4 2025 | 7 | $36.3M | GNR, USRT, IVV, IEFA, IEMG |
| Q3 2025 | 6 | $34.5M | GNR, USRT, IVV, IEFA, IEMG |
| Q2 2025 | 6 | $33.4M | GNR, IVV, USRT, IEFA, IEMG |
| Q1 2025 | 9 | $48.0M | GNR, AGG, GVI, USRT, IVV |
| Q4 2024 | 8 | $46.7M | GNR, AGG, GVI, USRT, IVV |
| Q3 2024 | 8 | $50.8M | GNR, AGG, GVI, USRT, IVV |
| Q2 2024 | 8 | $176.1M | IVV, IEFA, VWO, GNR, IEMG |
| Q1 2024 | 9 | $1.5B | IVV, IEFA, IEMG, ACWI, GNR |